login
login

Europe Daily Bulletin No. 13053

29 October 2022
Contents Publication in full By article 21 / 28
EU RESPONSE TO COVID-19 / Health
EMA publishes clinical trial supporting use of Comirnaty vaccine as a booster dose for children aged 5 to 11 years

Brussels, 28/10/2022 (Agence Europe)On Tuesday 25 October, the European Medicines Agency (EMA) announced the publication of the clinical trial supporting the use of Comirnaty, the mRNA SARS-CoV-2 vaccine developed by the pharmaceutical companies Pfizer and BioNTech, as a booster dose for children aged 5 to 11 years. The EMA specifies that the publication of these clinical trials is done under the exceptional measures related to the Covid-19 epidemic. These exceptional measures were...

Contents

SECTORAL POLICIES
Russian invasion of Ukraine
EXTERNAL ACTION
EU RESPONSE TO COVID-19
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
NEWS BRIEFS